The bone-seeking, α-particle-emitting radiopharmaceutical Alpharadin, 223RaCl2 (half-life=
11.4 days), is under clinical development as a novel treatment for skeletal metastases from …

The presence of distant metastases from differentiated thyroid carcinoma decreases the 10-
year survival of patients by 50%. Bone metastases represent a frequent complication …

Purpose: This Guideline is intended to provide a rational basis for the management of
patients with castration-resistant prostate cancer based on currently available published …

Targeted alpha-particle therapy (TAT) aims to selectively deliver radionuclides emitting α-
particles (cytotoxic payload) to tumors by chelation to monoclonal antibodies, peptides or …

The production of reactor-based medical isotopes is fragile, which has meant supply
shortages from time to time. This paper reviews alternative production methods in the form of …

Abstract The IUPAC (International Union of Pure and Applied Chemistry) Periodic Table of
the Elements and Isotopes (IPTEI) was created to familiarize students, teachers, and non …

Bone pain due to skeletal metastases constitutes the most common type of chronic pain
among patients with cancer. It significantly decreases the patient's quality of life and is …

Metastatic bone disease in patients with advanced cancer is frequently associated with
skeletal complications. These can be debilitating, causing pain, impaired functioning and …

(1) In radiation therapy, cancer is treated to preserve life and to improve the quality of life of
the patient. While radiation therapy focuses on treating the malignancy, absorbed doses …

Nuclear medicine continues to represent one of the important modalities for cancer
management. While diagnostic nuclear medicine for cancer management is fairly well …